nodes	percent_of_prediction	percent_of_DWPC	metapath
Pipotiazine—HTR2A—narcolepsy	0.853	1	CbGaD
Pipotiazine—HTR2A—enteric nervous system—narcolepsy	0.0153	0.215	CbGeAlD
Pipotiazine—HTR2A—locus ceruleus—narcolepsy	0.0101	0.142	CbGeAlD
Pipotiazine—HTR2A—pons—narcolepsy	0.00582	0.0818	CbGeAlD
Pipotiazine—HTR2A—autonomic nervous system—narcolepsy	0.00537	0.0754	CbGeAlD
Pipotiazine—DRD1—brainstem—narcolepsy	0.00333	0.0467	CbGeAlD
Pipotiazine—DRD1—forebrain—narcolepsy	0.00321	0.0451	CbGeAlD
Pipotiazine—SLC22A1—forebrain—narcolepsy	0.00254	0.0357	CbGeAlD
Pipotiazine—HTR1A—brainstem—narcolepsy	0.00218	0.0305	CbGeAlD
Pipotiazine—DRD1—midbrain—narcolepsy	0.00212	0.0298	CbGeAlD
Pipotiazine—HTR1A—forebrain—narcolepsy	0.0021	0.0295	CbGeAlD
Pipotiazine—DRD2—brainstem—narcolepsy	0.00197	0.0276	CbGeAlD
Pipotiazine—DRD2—forebrain—narcolepsy	0.0019	0.0266	CbGeAlD
Pipotiazine—HTR1A—midbrain—narcolepsy	0.00139	0.0195	CbGeAlD
Pipotiazine—DRD1—brain—narcolepsy	0.00133	0.0187	CbGeAlD
Pipotiazine—HTR2A—brainstem—narcolepsy	0.0013	0.0182	CbGeAlD
Pipotiazine—DRD2—midbrain—narcolepsy	0.00125	0.0176	CbGeAlD
Pipotiazine—HTR2A—forebrain—narcolepsy	0.00125	0.0176	CbGeAlD
Pipotiazine—CYP2D6—brainstem—narcolepsy	0.00118	0.0166	CbGeAlD
Pipotiazine—CYP2D6—forebrain—narcolepsy	0.00114	0.016	CbGeAlD
Pipotiazine—SLC22A1—brain—narcolepsy	0.00105	0.0148	CbGeAlD
Pipotiazine—ALB—brain—narcolepsy	0.00101	0.0142	CbGeAlD
Pipotiazine—HTR2A—medulla oblongata—narcolepsy	0.000904	0.0127	CbGeAlD
Pipotiazine—HTR1A—brain—narcolepsy	0.000871	0.0122	CbGeAlD
Pipotiazine—HTR2A—midbrain—narcolepsy	0.000826	0.0116	CbGeAlD
Pipotiazine—DRD2—brain—narcolepsy	0.000787	0.0111	CbGeAlD
Pipotiazine—Cyamemazine—HTR2A—narcolepsy	0.000778	0.106	CrCbGaD
Pipotiazine—Zuclopenthixol—HTR2A—narcolepsy	0.000558	0.0763	CrCbGaD
Pipotiazine—HTR2A—brain—narcolepsy	0.000519	0.00729	CbGeAlD
Pipotiazine—Acepromazine—HTR2A—narcolepsy	0.0005	0.0684	CrCbGaD
Pipotiazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.000499	0.00732	CbGpPWpGaD
Pipotiazine—DRD1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.000498	0.00729	CbGpPWpGaD
Pipotiazine—Thioproperazine—HTR2A—narcolepsy	0.000489	0.0668	CrCbGaD
Pipotiazine—DRD1—G alpha (s) signalling events—NPS—narcolepsy	0.000489	0.00716	CbGpPWpGaD
Pipotiazine—Thiothixene—HTR2A—narcolepsy	0.000481	0.0658	CrCbGaD
Pipotiazine—HTR2A—G alpha (q) signalling events—HCRT—narcolepsy	0.000475	0.00696	CbGpPWpGaD
Pipotiazine—Mesoridazine—HTR2A—narcolepsy	0.000475	0.0649	CrCbGaD
Pipotiazine—CYP2D6—brain—narcolepsy	0.000473	0.00664	CbGeAlD
Pipotiazine—DRD2—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.000454	0.00666	CbGpPWpGaD
Pipotiazine—DRD2—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.000454	0.00666	CbGpPWpGaD
Pipotiazine—HTR2A—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.000447	0.00655	CbGpPWpGaD
Pipotiazine—HTR2A—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.000447	0.00655	CbGpPWpGaD
Pipotiazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.000443	0.0065	CbGpPWpGaD
Pipotiazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.000443	0.0065	CbGpPWpGaD
Pipotiazine—DRD2—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.000439	0.00643	CbGpPWpGaD
Pipotiazine—HTR2A—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.000432	0.00633	CbGpPWpGaD
Pipotiazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.000428	0.00627	CbGpPWpGaD
Pipotiazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.000425	0.00622	CbGpPWpGaD
Pipotiazine—DRD1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.000423	0.0062	CbGpPWpGaD
Pipotiazine—Fluphenazine—HTR2A—narcolepsy	0.000416	0.0568	CrCbGaD
Pipotiazine—HTR1A—G alpha (i) signalling events—PENK—narcolepsy	0.000408	0.00598	CbGpPWpGaD
Pipotiazine—Propiomazine—HTR2A—narcolepsy	0.0004	0.0547	CrCbGaD
Pipotiazine—DRD1—GPCR ligand binding—HCRTR2—narcolepsy	0.000392	0.00575	CbGpPWpGaD
Pipotiazine—DRD1—GPCR ligand binding—HCRTR1—narcolepsy	0.000392	0.00575	CbGpPWpGaD
Pipotiazine—DRD2—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.000389	0.0057	CbGpPWpGaD
Pipotiazine—DRD2—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.000389	0.0057	CbGpPWpGaD
Pipotiazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.000383	0.00561	CbGpPWpGaD
Pipotiazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.000383	0.00561	CbGpPWpGaD
Pipotiazine—Clomipramine—HTR2A—narcolepsy	0.00038	0.052	CrCbGaD
Pipotiazine—DRD1—GPCR ligand binding—P2RY11—narcolepsy	0.000379	0.00555	CbGpPWpGaD
Pipotiazine—DRD1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.000377	0.00553	CbGpPWpGaD
Pipotiazine—DRD2—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.000376	0.00551	CbGpPWpGaD
Pipotiazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00037	0.00542	CbGpPWpGaD
Pipotiazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.000364	0.00533	CbGpPWpGaD
Pipotiazine—HTR2A—G alpha (q) signalling events—TRH—narcolepsy	0.00036	0.00527	CbGpPWpGaD
Pipotiazine—DRD2—G alpha (i) signalling events—PENK—narcolepsy	0.000358	0.00525	CbGpPWpGaD
Pipotiazine—Thioridazine—HTR2A—narcolepsy	0.000358	0.049	CrCbGaD
Pipotiazine—HTR1A—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.00035	0.00513	CbGpPWpGaD
Pipotiazine—Methotrimeprazine—HTR2A—narcolepsy	0.000342	0.0468	CrCbGaD
Pipotiazine—HTR1A—GPCR ligand binding—HCRTR2—narcolepsy	0.000337	0.00495	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR ligand binding—HCRTR1—narcolepsy	0.000337	0.00495	CbGpPWpGaD
Pipotiazine—Promethazine—HTR2A—narcolepsy	0.000337	0.0461	CrCbGaD
Pipotiazine—Trifluoperazine—HTR2A—narcolepsy	0.000332	0.0454	CrCbGaD
Pipotiazine—DRD1—Circadian rythm related genes—NPS—narcolepsy	0.000332	0.00487	CbGpPWpGaD
Pipotiazine—Perphenazine—HTR2A—narcolepsy	0.000329	0.0449	CrCbGaD
Pipotiazine—DRD1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.000328	0.00481	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR ligand binding—P2RY11—narcolepsy	0.000326	0.00478	CbGpPWpGaD
Pipotiazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.000324	0.00475	CbGpPWpGaD
Pipotiazine—Quetiapine—HTR2A—narcolepsy	0.000322	0.0441	CrCbGaD
Pipotiazine—DRD1—GPCR ligand binding—HCRT—narcolepsy	0.000322	0.00472	CbGpPWpGaD
Pipotiazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.000322	0.00472	CbGpPWpGaD
Pipotiazine—DRD1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.000321	0.0047	CbGpPWpGaD
Pipotiazine—DRD2—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.000319	0.00468	CbGpPWpGaD
Pipotiazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.000314	0.00461	CbGpPWpGaD
Pipotiazine—HTR1A—G alpha (i) signalling events—HRH3—narcolepsy	0.000304	0.00446	CbGpPWpGaD
Pipotiazine—HTR2A—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.000302	0.00443	CbGpPWpGaD
Pipotiazine—DRD2—GPCR ligand binding—HCRTR2—narcolepsy	0.000296	0.00434	CbGpPWpGaD
Pipotiazine—DRD2—GPCR ligand binding—HCRTR1—narcolepsy	0.000296	0.00434	CbGpPWpGaD
Pipotiazine—Promazine—HTR2A—narcolepsy	0.000296	0.0405	CrCbGaD
Pipotiazine—HTR2A—GPCR ligand binding—HCRTR1—narcolepsy	0.000292	0.00427	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR ligand binding—HCRTR2—narcolepsy	0.000292	0.00427	CbGpPWpGaD
Pipotiazine—DRD1—GPCR ligand binding—PENK—narcolepsy	0.000287	0.00421	CbGpPWpGaD
Pipotiazine—DRD2—GPCR ligand binding—P2RY11—narcolepsy	0.000286	0.00419	CbGpPWpGaD
Pipotiazine—DRD2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.000285	0.00417	CbGpPWpGaD
Pipotiazine—HTR1A—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.000282	0.00414	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR ligand binding—P2RY11—narcolepsy	0.000282	0.00413	CbGpPWpGaD
Pipotiazine—DRD1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.000281	0.00412	CbGpPWpGaD
Pipotiazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00028	0.00411	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR ligand binding—HCRT—narcolepsy	0.000277	0.00406	CbGpPWpGaD
Pipotiazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.000276	0.00404	CbGpPWpGaD
Pipotiazine—DRD2—G alpha (i) signalling events—HRH3—narcolepsy	0.000267	0.00391	CbGpPWpGaD
Pipotiazine—HTR2A—G alpha (q) signalling events—TAC1—narcolepsy	0.000261	0.00383	CbGpPWpGaD
Pipotiazine—HTR2A—G alpha (q) signalling events—NPS—narcolepsy	0.000261	0.00383	CbGpPWpGaD
Pipotiazine—Chlorpromazine—HTR2A—narcolepsy	0.000261	0.0357	CrCbGaD
Pipotiazine—Imipramine—HTR2A—narcolepsy	0.000259	0.0355	CrCbGaD
Pipotiazine—DRD2—Circadian rythm related genes—NPS—narcolepsy	0.000251	0.00368	CbGpPWpGaD
Pipotiazine—DRD2—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.000248	0.00363	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR ligand binding—PENK—narcolepsy	0.000247	0.00362	CbGpPWpGaD
Pipotiazine—DRD1—GPCR ligand binding—TRH—narcolepsy	0.000244	0.00358	CbGpPWpGaD
Pipotiazine—HTR2A—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.000244	0.00357	CbGpPWpGaD
Pipotiazine—DRD2—GPCR ligand binding—HCRT—narcolepsy	0.000243	0.00357	CbGpPWpGaD
Pipotiazine—DRD2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.000242	0.00355	CbGpPWpGaD
Pipotiazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.000242	0.00354	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR ligand binding—HCRT—narcolepsy	0.000239	0.00351	CbGpPWpGaD
Pipotiazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.000238	0.00349	CbGpPWpGaD
Pipotiazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.000234	0.00343	CbGpPWpGaD
Pipotiazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.000234	0.00343	CbGpPWpGaD
Pipotiazine—DRD1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000233	0.00342	CbGpPWpGaD
Pipotiazine—DRD1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000233	0.00342	CbGpPWpGaD
Pipotiazine—DRD1—GPCR downstream signaling—HCRTR2—narcolepsy	0.000222	0.00325	CbGpPWpGaD
Pipotiazine—DRD1—GPCR downstream signaling—HCRTR1—narcolepsy	0.000222	0.00325	CbGpPWpGaD
Pipotiazine—DRD2—GPCR ligand binding—PENK—narcolepsy	0.000217	0.00318	CbGpPWpGaD
Pipotiazine—DRD1—GPCR downstream signaling—P2RY11—narcolepsy	0.000214	0.00314	CbGpPWpGaD
Pipotiazine—DRD1—GPCR ligand binding—HRH3—narcolepsy	0.000214	0.00314	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR ligand binding—PENK—narcolepsy	0.000213	0.00313	CbGpPWpGaD
Pipotiazine—DRD2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.000212	0.00311	CbGpPWpGaD
Pipotiazine—HTR1A—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00021	0.00308	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR ligand binding—TRH—narcolepsy	0.00021	0.00308	CbGpPWpGaD
Pipotiazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.000209	0.00306	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—HCRTR1—narcolepsy	0.000201	0.00295	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—HCRTR2—narcolepsy	0.000201	0.00295	CbGpPWpGaD
Pipotiazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.0002	0.00294	CbGpPWpGaD
Pipotiazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.0002	0.00294	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—P2RY11—narcolepsy	0.000194	0.00285	CbGpPWpGaD
Pipotiazine—ALB—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000194	0.00284	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR downstream signaling—HCRTR2—narcolepsy	0.000191	0.0028	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR downstream signaling—HCRTR1—narcolepsy	0.000191	0.0028	CbGpPWpGaD
Pipotiazine—DRD2—GPCR ligand binding—TRH—narcolepsy	0.000184	0.0027	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR downstream signaling—P2RY11—narcolepsy	0.000184	0.0027	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR ligand binding—HRH3—narcolepsy	0.000184	0.0027	CbGpPWpGaD
Pipotiazine—DRD1—GPCR downstream signaling—HCRT—narcolepsy	0.000182	0.00267	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR ligand binding—TRH—narcolepsy	0.000181	0.00266	CbGpPWpGaD
Pipotiazine—DRD1—GPCR ligand binding—TAC1—narcolepsy	0.000177	0.0026	CbGpPWpGaD
Pipotiazine—DRD1—GPCR ligand binding—NPS—narcolepsy	0.000177	0.0026	CbGpPWpGaD
Pipotiazine—DRD2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000176	0.00258	CbGpPWpGaD
Pipotiazine—DRD2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000176	0.00258	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000174	0.00255	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—HCRTR1—narcolepsy	0.000173	0.00254	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—HCRTR2—narcolepsy	0.000173	0.00254	CbGpPWpGaD
Pipotiazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000173	0.00254	CbGpPWpGaD
Pipotiazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000173	0.00254	CbGpPWpGaD
Pipotiazine—DRD2—GPCR downstream signaling—HCRTR1—narcolepsy	0.000167	0.00245	CbGpPWpGaD
Pipotiazine—DRD2—GPCR downstream signaling—HCRTR2—narcolepsy	0.000167	0.00245	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—P2RY11—narcolepsy	0.000167	0.00245	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—HCRT—narcolepsy	0.000165	0.00242	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR downstream signaling—HCRTR2—narcolepsy	0.000165	0.00241	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR downstream signaling—HCRTR1—narcolepsy	0.000165	0.00241	CbGpPWpGaD
Pipotiazine—DRD1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000164	0.0024	CbGpPWpGaD
Pipotiazine—DRD1—GPCR downstream signaling—PENK—narcolepsy	0.000162	0.00238	CbGpPWpGaD
Pipotiazine—DRD2—GPCR downstream signaling—P2RY11—narcolepsy	0.000162	0.00237	CbGpPWpGaD
Pipotiazine—DRD2—GPCR ligand binding—HRH3—narcolepsy	0.000162	0.00237	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR downstream signaling—P2RY11—narcolepsy	0.000159	0.00233	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR ligand binding—HRH3—narcolepsy	0.000159	0.00233	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR downstream signaling—HCRT—narcolepsy	0.000157	0.0023	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR ligand binding—TAC1—narcolepsy	0.000153	0.00224	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR ligand binding—NPS—narcolepsy	0.000153	0.00224	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—HCRTR1—narcolepsy	0.000152	0.00223	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—HCRTR2—narcolepsy	0.000152	0.00223	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—HCRTR1—narcolepsy	0.00015	0.00219	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—HCRTR2—narcolepsy	0.00015	0.00219	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—PENK—narcolepsy	0.000147	0.00216	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—P2RY11—narcolepsy	0.000147	0.00215	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—P2RY11—narcolepsy	0.000144	0.00212	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—HCRT—narcolepsy	0.000142	0.00208	CbGpPWpGaD
Pipotiazine—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000141	0.00206	CbGpPWpGaD
Pipotiazine—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00014	0.00205	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR downstream signaling—PENK—narcolepsy	0.00014	0.00205	CbGpPWpGaD
Pipotiazine—DRD1—GPCR downstream signaling—TRH—narcolepsy	0.000138	0.00202	CbGpPWpGaD
Pipotiazine—DRD2—GPCR downstream signaling—HCRT—narcolepsy	0.000137	0.00202	CbGpPWpGaD
Pipotiazine—ALB—Vitamin B12 Metabolism—TNF—narcolepsy	0.000137	0.00201	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000135	0.00198	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR downstream signaling—HCRT—narcolepsy	0.000135	0.00198	CbGpPWpGaD
Pipotiazine—DRD2—GPCR ligand binding—TAC1—narcolepsy	0.000134	0.00196	CbGpPWpGaD
Pipotiazine—DRD2—GPCR ligand binding—NPS—narcolepsy	0.000134	0.00196	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR ligand binding—NPS—narcolepsy	0.000132	0.00193	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR ligand binding—TAC1—narcolepsy	0.000132	0.00193	CbGpPWpGaD
Pipotiazine—ALB—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000132	0.00193	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—CHKB—narcolepsy	0.000129	0.00189	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—PENK—narcolepsy	0.000127	0.00186	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—TRH—narcolepsy	0.000125	0.00184	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—HCRT—narcolepsy	0.000125	0.00183	CbGpPWpGaD
Pipotiazine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000124	0.00181	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—HCRT—narcolepsy	0.000123	0.0018	CbGpPWpGaD
Pipotiazine—DRD2—GPCR downstream signaling—PENK—narcolepsy	0.000123	0.0018	CbGpPWpGaD
Pipotiazine—DRD1—GPCR downstream signaling—HRH3—narcolepsy	0.000121	0.00177	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR downstream signaling—PENK—narcolepsy	0.000121	0.00177	CbGpPWpGaD
Pipotiazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000121	0.00177	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—HCRTR2—narcolepsy	0.000119	0.00174	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—HCRTR1—narcolepsy	0.000119	0.00174	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR downstream signaling—TRH—narcolepsy	0.000119	0.00174	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000118	0.00173	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—P2RY11—narcolepsy	0.000115	0.00168	CbGpPWpGaD
Pipotiazine—ALB—Folate Metabolism—TNF—narcolepsy	0.000112	0.00164	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—PENK—narcolepsy	0.000111	0.00163	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—HRH3—narcolepsy	0.00011	0.00161	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—PENK—narcolepsy	0.000109	0.0016	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—TRH—narcolepsy	0.000108	0.00158	CbGpPWpGaD
Pipotiazine—DRD1—GPCR ligand binding—HTR2A—narcolepsy	0.000107	0.00156	CbGpPWpGaD
Pipotiazine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000106	0.00155	CbGpPWpGaD
Pipotiazine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—narcolepsy	0.000104	0.00153	CbGpPWpGaD
Pipotiazine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—narcolepsy	0.000104	0.00153	CbGpPWpGaD
Pipotiazine—DRD2—GPCR downstream signaling—TRH—narcolepsy	0.000104	0.00153	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR downstream signaling—HRH3—narcolepsy	0.000104	0.00153	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR downstream signaling—TRH—narcolepsy	0.000103	0.0015	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—HCRTR2—narcolepsy	0.000102	0.0015	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—HCRTR1—narcolepsy	0.000102	0.0015	CbGpPWpGaD
Pipotiazine—DRD1—GPCR downstream signaling—TAC1—narcolepsy	0.0001	0.00147	CbGpPWpGaD
Pipotiazine—DRD1—GPCR downstream signaling—NPS—narcolepsy	0.0001	0.00147	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—P2RY11—narcolepsy	9.88e-05	0.00145	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—HCRT—narcolepsy	9.77e-05	0.00143	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—TRH—narcolepsy	9.46e-05	0.00139	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—HRH3—narcolepsy	9.45e-05	0.00139	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—TRH—narcolepsy	9.31e-05	0.00136	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	9.2e-05	0.00135	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR ligand binding—HTR2A—narcolepsy	9.18e-05	0.00135	CbGpPWpGaD
Pipotiazine—DRD2—GPCR downstream signaling—HRH3—narcolepsy	9.14e-05	0.00134	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—TAC1—narcolepsy	9.11e-05	0.00133	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—NPS—narcolepsy	9.11e-05	0.00133	CbGpPWpGaD
Pipotiazine—HTR1A—SIDS Susceptibility Pathways—TNF—narcolepsy	9.05e-05	0.00133	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR downstream signaling—HRH3—narcolepsy	8.99e-05	0.00132	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—HCRTR1—narcolepsy	8.98e-05	0.00132	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—HCRTR2—narcolepsy	8.98e-05	0.00132	CbGpPWpGaD
Pipotiazine—ALB—Selenium Micronutrient Network—TNF—narcolepsy	8.87e-05	0.0013	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—HCRTR2—narcolepsy	8.84e-05	0.0013	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—HCRTR1—narcolepsy	8.84e-05	0.0013	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—CPT1B—narcolepsy	8.76e-05	0.00128	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—PENK—narcolepsy	8.71e-05	0.00128	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—P2RY11—narcolepsy	8.67e-05	0.00127	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR downstream signaling—TAC1—narcolepsy	8.62e-05	0.00126	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR downstream signaling—NPS—narcolepsy	8.62e-05	0.00126	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—CHKB—narcolepsy	8.62e-05	0.00126	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—P2RY11—narcolepsy	8.54e-05	0.00125	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—HCRT—narcolepsy	8.4e-05	0.00123	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—HRH3—narcolepsy	8.3e-05	0.00122	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—HRH3—narcolepsy	8.16e-05	0.0012	CbGpPWpGaD
Pipotiazine—DRD2—GPCR ligand binding—HTR2A—narcolepsy	8.06e-05	0.00118	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—NPS—narcolepsy	7.83e-05	0.00115	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—TAC1—narcolepsy	7.83e-05	0.00115	CbGpPWpGaD
Pipotiazine—HTR2A—SIDS Susceptibility Pathways—TNF—narcolepsy	7.82e-05	0.00115	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—CHKB—narcolepsy	7.74e-05	0.00113	CbGpPWpGaD
Pipotiazine—DRD2—GPCR downstream signaling—NPS—narcolepsy	7.57e-05	0.00111	CbGpPWpGaD
Pipotiazine—DRD2—GPCR downstream signaling—TAC1—narcolepsy	7.57e-05	0.00111	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—PENK—narcolepsy	7.49e-05	0.0011	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR downstream signaling—TAC1—narcolepsy	7.45e-05	0.00109	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR downstream signaling—NPS—narcolepsy	7.45e-05	0.00109	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—TRH—narcolepsy	7.4e-05	0.00109	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—HCRT—narcolepsy	7.38e-05	0.00108	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—HCRT—narcolepsy	7.26e-05	0.00106	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—CHKB—narcolepsy	7.12e-05	0.00104	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—NPS—narcolepsy	6.88e-05	0.00101	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—TAC1—narcolepsy	6.88e-05	0.00101	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—TAC1—narcolepsy	6.76e-05	0.000992	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—NPS—narcolepsy	6.76e-05	0.000992	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—PENK—narcolepsy	6.57e-05	0.000964	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—HRH3—narcolepsy	6.49e-05	0.000952	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—PENK—narcolepsy	6.47e-05	0.000948	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—TRH—narcolepsy	6.37e-05	0.000933	CbGpPWpGaD
Pipotiazine—DRD1—GPCR downstream signaling—HTR2A—narcolepsy	6.03e-05	0.000884	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—CHKB—narcolepsy	6.03e-05	0.000884	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—CPT1B—narcolepsy	5.86e-05	0.000859	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—TRH—narcolepsy	5.59e-05	0.000819	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—HRH3—narcolepsy	5.58e-05	0.000818	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—TRH—narcolepsy	5.5e-05	0.000806	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—HTR2A—narcolepsy	5.48e-05	0.000803	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—TAC1—narcolepsy	5.38e-05	0.000788	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—NPS—narcolepsy	5.38e-05	0.000788	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—CPT1B—narcolepsy	5.26e-05	0.000771	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR downstream signaling—HTR2A—narcolepsy	5.19e-05	0.00076	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—HRH3—narcolepsy	4.9e-05	0.000718	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—CPT1B—narcolepsy	4.84e-05	0.000709	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—HRH3—narcolepsy	4.82e-05	0.000707	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—HTR2A—narcolepsy	4.71e-05	0.00069	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—CHKB—narcolepsy	4.65e-05	0.000682	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—NPS—narcolepsy	4.63e-05	0.000678	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—TAC1—narcolepsy	4.63e-05	0.000678	CbGpPWpGaD
Pipotiazine—DRD2—GPCR downstream signaling—HTR2A—narcolepsy	4.55e-05	0.000668	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—HTR2A—narcolepsy	4.14e-05	0.000606	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—CPT1B—narcolepsy	4.1e-05	0.000601	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—TAC1—narcolepsy	4.06e-05	0.000595	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—NPS—narcolepsy	4.06e-05	0.000595	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—TAC1—narcolepsy	4e-05	0.000586	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—NPS—narcolepsy	4e-05	0.000586	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—HTR2A—narcolepsy	3.24e-05	0.000474	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—CPT1B—narcolepsy	3.16e-05	0.000464	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—HTR2A—narcolepsy	2.78e-05	0.000408	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—HTR2A—narcolepsy	2.44e-05	0.000358	CbGpPWpGaD
